Despite studies implicating adipose tissue T cells (ATT) in the initiation and persistence of adipose tissue inflammation, fundamental gaps in knowledge regarding ATT function impedes progress toward understanding how obesity influences adaptive immunity. We hypothesized that ATT activation and function would have tissue-resident–specific properties and that obesity would potentiate their inflammatory properties. We assessed ATT activation and inflammatory potential within mouse and human stromal vascular fraction (SVF). Surprisingly, murine and human ATTs from obese visceral white adipose tissue exhibited impaired inflammatory characteristics upon stimulation. Both environmental and cell-intrinsic factors are implicated in ATT dysfunction. Soluble factors from obese SVF inhibit ATT activation. Additionally, chronic signaling from macrophage major histocompatibility complex II (MHCII) is necessary for ATT impairment in obese adipose tissue but is independent of increased PD1 expression. To assess intracellular signaling mechanisms responsible for ATT inflammation impairments, single-cell RNA sequencing of ATTs was performed. ATTs in obese adipose tissue exhibit enrichment of genes characteristic of T cell exhaustion and increased expression of coinhibitory receptor Btla. In sum, this work suggests that obesity-induced ATTs have functional characteristics and gene expression resembling T cell exhaustion induced by local soluble factors and cell-to-cell interactions in adipose tissue.
Cara E. Porsche, Jennifer B. Delproposto, Lynn Geletka, Robert O’Rourke, Carey N. Lumeng
Title and authors | Publication | Year |
---|---|---|
Fat-to-blood recirculation of partially dysfunctional PD-1+CD4 Tconv cells is associated with dysglycemia in human obesity.
Anna Giovenzana, Eugenia Bezzecchi, Anita Bichisecchi, Sara Cardellini, Francesca Ragogna, Federica Pedica, Federica Invernizzi, Luigi Filippo, Valentina Tomajer, Francesca Aleotti, Giulia Scotti, Carlo Socci, Giovanni Cesana, Stefano Olmi, Marco Morelli, Massimo Falconi, Andrea Giustina, Chiara Bonini, Lorenzo Piemonti, Eliana Ruggiero, Alessandra Petrelli |
iScience | 2024 |
Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer.
Ramoni D, Coco S, Rossi G, Dellepiane C, Bennicelli E, Santamaria S, Zinoli L, Tagliafico AS, Tagliamento M, Barletta G, Liberale L, Tirandi A, Minetti S, Bertolotto M, Montecucco F, Genova C, Carbone F |
Lung | 2024 |
The Role of Neutral Sphingomyelinase-2 (NSM2) in the Control of Neutral Lipid Storage in T Cells
Schempp R, Eilts J, Schöl M, Grijalva Yépez MF, Fekete A, Wigger D, Schumacher F, Kleuser B, van Ham M, Jänsch L, Sauer M, Avota E |
International journal of molecular sciences | 2024 |
New insight of chemical constituents in Persea americana fruit against obesity via integrated pharmacology
Cha M, Lee S, Yoon S, Lee SY, Gupta H, Ganesan R, Sharma SP, Won S, Jeong J, Kim DJ, Oh K, Suk K |
Clinical and Translational Science | 2024 |
Potential roles of sex-linked differences in obesity and cancer immunotherapy: revisiting the obesity paradox
Vick LV, Rosario S, Riess JW, Canter RJ, Mukherjee S, Monjazeb AM, Murphy WJ |
2024 | |
Chronic immune-related adverse events arising from immune checkpoint inhibitors: an update
Fletcher K, Johnson DB |
Journal for ImmunoTherapy of Cancer | 2024 |
T cell trafficking in human chronic inflammatory diseases.
Giovenzana A, Codazzi V, Pandolfo M, Petrelli A |
iScience | 2024 |
Obesity-compromised immunity in post-COVID-19 condition: a critical control point of chronicity
Jang S, Hong W, Moon Y |
Frontiers in Immunology | 2024 |
Research progress on the role of adipocyte exosomes in cancer progression.
Wang Y, Li X, Liu D, Wang Z, Xia J, Wang L, Zhang X |
Oncology research | 2024 |
Regulation of CD8+ T cells by lipid metabolism in cancer progression.
Tang Y, Chen Z, Zuo Q, Kang Y |
Cellular & molecular immunology | 2024 |